Status:
ACTIVE_NOT_RECRUITING
E-cigarette Harm Reduction Among PLWHA in South Africa
Lead Sponsor:
NYU Langone Health
Collaborating Sponsors:
Fogarty International Center of the National Institute of Health
Conditions:
Tobacco Smoking
Eligibility:
All Genders
18-70 years
Phase:
PHASE1
Brief Summary
The purpose of this pilot randomized controlled trial study aims to address the unmet need for feasible and efficacious strategies for reducing combustible cigarette (CC) use among people living with ...
Eligibility Criteria
Inclusion
- Adult PLWHA CC smokers;
- Speaks Afrikaans, or Xhosa, or English;
- reports daily CC smoking (≥ 5 CPD);
- Owns any type of mobile phone;
- interested in reducing CC smoking but not necessarily trying to quit;
- Receives HIV/AIDS care in one of the eight selected clinics follow-up rates.
Exclusion
- are pregnant or breastfeeding;
- unable to provide consent;
- used tobacco products other than CC in the past 2 weeks (e.g., EC, cigarillo);
- currently engaged in an attempt to quit CC smoking;
- current major depressive or manic episode, current psychotic disorder, past-year suicide attempt, or current suicidal ideation with plan or intent. plan or intent.
Key Trial Info
Start Date :
April 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 27 2026
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT06169813
Start Date
April 15 2025
End Date
February 27 2026
Last Update
November 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
South African Medical Research Council (SAMRC)
Cape Town, South Africa, 7501